Clarke Barlow

Clarke Barlow

Founder at AMG ACQUISITION CORP.

Net worth: 18 997 $ as of 31/10/2023

43 year
Health Technology
Finance
Consumer Services

Profile

Clarke Barlow is the founder of AMG Acquisition Corp., which was founded in 2021.
He is currently the Director at Neuroscientific Biopharmaceuticals Ltd.
since 2023, Non-Executive Director at Tryptamine Therapeutics Ltd.
since 2024, and a Member at the Australian Institute of Co. Directors.
He previously served as a Non-Executive Director at Exopharm Ltd.
Mr. Barlow completed his undergraduate degree at The University of Western Australia.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/04/2023 533,340 ( 6.84% ) 15 467 $ 30/04/2024
0.12%
01/05/2024 508,000 ( 0.12% ) 3 531 $ 31/10/2023

Clarke Barlow active positions

CompaniesPositionStart
AMG ACQUISITION CORP. Founder 01/06/2021
NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED Director/Board Member 17/11/2023
Corporate Officer/Principal -
All active positions of Clarke Barlow

Former positions of Clarke Barlow

CompaniesPositionEnd
EXOPHARM Director/Board Member -
See the detail of Clarke Barlow's experience

Training of Clarke Barlow

The University of Western Australia Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Clarke Barlow's experience

Connections

100 +

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
AMG ACQUISITION CORP.

Finance

NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED

Health Technology

Private companies2

Commercial Services

Health Technology

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW